Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword
Progress in Cardiovascular Diseases · 2025
DOI: 10.1016/j.pcad.2024.11.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Progress in Cardiovascular Diseases, 2025. Verfasst von Evan L O'Keefe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO, United States of America. Hauptthemen laut MEDLINE: Atrial Fibrillation, Eicosapentaenoic Acid, Docosahexaenoic Acids, Vagus Nerve. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: Studies regarding effects of omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on risk of atrial fibrillation (AF) have reported discordant results. The aim of this review is to clarify effects of marine omega-3 intake on risk of AF. PATIENTS AND METHODS: A PubMed search was performed using terms: atrial fibrillation, omega-3, EPA, DHA, vagal tone. We summarized findings from randomized clinical trials (RCTs), epidemiology studies, and meta-analyses evaluating effects/associations of DHA + EPA on risk of AF. Also, vagal tone was explored as a mediator between omega-3 and risk of AF. RESULTS: Meta-analyses of 8 RCTs and 17 prospective cohort studies comprised of 83,112 and 54,799 individuals, respectively, investigated the link between omega-3 intake and incident AF. The RCTs reported that treatment with DHA and/or EPA was associated with a 24 % increased relative risk of AF (absolute risk 4.0 % vs 3.3 %; relative risk [RR] 1.24, 95 % confidence interval [CI] 1.11-1.38, p = 0.0002). This was dose-dependent; DHA + EPA doses of ∼1000 mg/d increased AF risk ∼12 %, whereas 1800 to 4000 mg/d increased AF risk by ∼50 %. In contrast, observational studies focused on DHA + EPA blood levels or dietary intake have generally reported that higher omega-3 levels/consumption are associated with lower AF risk. Maximal AF risk reduction. (12 %) occurred at ∼650 mg/d of dietary DHA + EPA. Other studies have indicated that omega-3 fatty acids can dose-dependently increase vagal tone, which could explain the biphasic relationship between DHA + EPA and AF risk. Experimental studies show that low-level vagal stimulation decreases risk of AF, whereas high-level vagal stimulation increases risk of AF. CONCLUSION: Higher consumption of dietary omega-3 is associated with decreased AF risk. In contrast, pharmaceutical dosing of omega-3 increases AF in a dose-dependent manner, which may be mediated by vagal tone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO, United States of America.
- Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO, United States of America. Electronic address: jokeefe@saintlukeskc.org.
- Department of Clinical Cardiac Electrophysiology, Creighton University School of Medicine, Omaha, NE, United States of America.
- Oschner Heart and Vascular Institute, New Orleans, LA, United States of America.
- Fatty Acid Research Institute, Sioux Falls, SD, United States of America; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, United States of America.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- National Institutes of Health
Zitieren
APA
O'Keefe, E. L., O'Keefe, J. H., Abuissa, H., Metzinger, M., Murray, E., Franco, G., Lavie, C. J., & Harris, W. S. (2025). Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2024.11.003
Vancouver
O'Keefe EL, O'Keefe JH, Abuissa H, Metzinger M, Murray E, Franco G, et al. Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword. Progress in Cardiovascular Diseases. 2025. doi:10.1016/j.pcad.2024.11.003
BibTeX
@article{OKeefe2025,
author = {O'Keefe, Evan L and O'Keefe, James H and Abuissa, Hussam and Metzinger, Mark and Murray, Ellen and Franco, Grant and Lavie, Carl J and Harris, William S},
title = {Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword},
journal = {Progress in Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.pcad.2024.11.003}
}
EUVIMED